This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
1 DM Smith , K McKenna , CJ Thompson . Hyponatraemia. Clin Endocrin 2000; 52: 667–78.
3 GE Hoyle , M Chua , RL Soiza . Prevalence of hyponatremia in elderly patients. J Am Geriatr Soc 2006; 54: 1473.
5 AK Johnson , RL Thunhorst . The neuroendocrinology of thirst and salt appetite: visceral sensory signals and mechanisms of central integration. Frontiers Neuroendocrinol 1997; 18: 292–353.
6 AE Luckey , CJ Parsa . Fluid and electrolytes in the aged. Arch Surg 2003; 138: 1055–60.
8 M Miller . Fluid and electrolyte homeostasis in the elderly: physiological changes of ageing and clinical consequences. Bailliere's Clin Endocrin Metabol 1997; 11: 367–87.
9 S Kumar , T Berl . Sodium. Lancet 1998; 352: 220–28.
10 CRV Tomson . Recent advances: Nephrology. Br Med J 2000; 320: 98–101.
11 L Cao , P Joshi , D Sumoza . Renal salt-wasting syndrome in a patient with cisplatin-induced hyponatremia: case report. Am J Clin Oncol 2002; 25: 344–46.
12 M Cerda-Esteve , E Cuadrado-Godia , JJ Chillaron Cerebral salt wasting syndrome: review. Eur J Intern Med 2008; 19: 249–54.
13 JK Maesaka , S Gupta , S Fishbane . Cerebral salt-wasting syndrome: does it exist? Nephron 1999; 82: 100–9.
16 EJ Hoorn , ML Halperin , R Zietse . Diagnostic approach to a patient with hyponatraemia: traditional versus physiology-based options. Q J Med 2005; 98: 529–40.
18 BF Palmer , JR Gates , M Lader . Causes and management of hyponatremia. Ann Pharmacother 2003; 37: 1694–1702.
19 HJ Adrogue , NE Madias . Primary care: Hyponatremia. NEJM 2000; 342: 1581–89.
20 M Chua , GE Hoyle , RL Soiza . Prognostic implications of hyponatremia in elderly hospitalized patients. Arch Gerontol Geriatr 2007; 45: 253–8.
21 B Renneboog , W Musch , X Vandemergel Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits. Am J Med 2006; 119: 71.e1–71.e8.
23 C Palm , D Reimann , P Gross . The role of V2 vasopressin antagonists in hyponatremia. Cardiovasc Res 2001; 51: 403–8.
25 G Passare , M Viitanen , O Torring , B Winblad , J Fastbom . Sodium and potassium disturbances in the elderly: prevalence and association with drug use. Clin Drug Invest 2004; 24: 535–44.
27 NA Snyder , DW Feifal , AI Arieff . Hypernatremia in elderly patients: a hetereogenous, morbid and iatrogenic entity. Ann Intern Med 1987; 107: 309–19.
28 PA Phillips , BJ Rolls , JG Ledingham Reduced thirst after water deprivation in healthy elderly men. N Engl J Med 1984; 311: 753–59.
29 SW Kim . Hypernatremia: Successful treatment. Electrolyte Blood Pressure 2006; 4: 66–71.
30 T Yamamoto , H Harada , J Fukuyama , T Hayashi , I Mori . Impaired arginine-vasopressin secretion associated with hypoangiotensionemia in hypernatremic dehydrated elderly patients. JAMA 1988; 259: 1039–42.
32 DG Bichet . Vasopressin receptors in health and disease. Kidney Int 1996; 49: 1706–11.
33 PM Palevsky , R Bhagrath , A Greenberg . Hypernatremia in hospitalized patients. Ann Inten Med 1996; 124: 197–203.
34 Y Ofran , D Lavi , D Opher , Ta Weiss , E Elinav . Fatal voluntary salt intake resulting in the highest ever documented sodium plasma level in adults (255 mmol L−1): a disorder linked to female gender and psychiatric disorders. J Internal Med 2004; 256: 525–28.
35 CR Gross , RD Lindquist , AC Wooley Clinical indicators of dehydration severity in elderly patients. J Emerg Med 1992; 10: 267–74.
36 P Chassagne , L Druesne , C Capet , JF Menard , E Bercoff . Clinical presentation of hypernatremia in elderly patients: a case-control study. J Am Geriatr Soc 2006; 54: 1225–30.
38 CA Long , P Marin , AJ Bayer , HGM Shetty , MSJ Pathy . Hypernatraemia in an adult in-patient population. Postgrad Med J 1991; 67: 643–45.
43 MS Dunnill , W Halley . Some observations on the quantitative anatomy of the kidney. J Pathol 1973; 110: 113–21.
44 RD Lindeman , J Tobin , NW Shock . Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 1985; 33: 278–85.
45 C McGreevy , J Horan , D Jones A study of tubular secretory capacity in older people with hyperkalaemia. J Nutr Health Aging 2008; 12: 152–55.
46 C Musso , V Liakopoulos , R De Miguel , N Imperiali , Algranati L. Transtubular potassium gradient: comparison between healthy old people and chronic renal failure patients. Int Urol Nephrol 2006; 38: 387–90.
47 P Weidmann , S Demyttenaere-Bursztein , MH Maxwell , J DeLima . Effect of aging on plasma renin and aldosterone in normal man. Kidney Int 1975; 8: 325–33.
48 MF Michelis . Hyperkalaemia in the elderly. Am J Kidney Dis 1990; 16: 296–99.
50 A Kudoh , T Sakai , H Ishihara , A Matsuki . Renin–aldosterone in elderly patients with hyperkalaemia under anaesthesia. Eur J Anaesthesiol 1999; 16: 231–35.
51 RA DeFronzo , R Lee , A Jones , M Bia . Effect of insulinopenia and adrenal hormone deficiency on acute potassium tolerance. Kidney Int 1980; 17: 586–94.
52 H Ikram . Arrhythmias, electrolytes, and ACE inhibitor therapy in the elderly. Gerontology 1987; 33: 42–47.
53 T Rosenthal , A Shamiss , E Holtzman . Dietary electrolytes and hypertension in the elderly. Int Urol Nephrol 2001; 33: 575–82.
55 Rastergar , M Soleimani . Hypokalaemia and hyperkalaemia. Postgrad Med J 2001; 77: 759–64.
56 AK Saggar-Malik , Cappuccio FP. Potassium supplements and potassium-sparing diuretics. A review and guide to appropriate use. Drugs 1993; 46: 986–1008.
58 LV Franse , M Pahor , M Di Bari Hypokalemia associated with diuretic use and cardiovascular events in the systolic hypertension in the elderly program. Hypertension 2000; 35: 1025–30.
59 P Ahee , AV Crowe . The management of hyperkalaemia in the emergency department. J Accid Emerg Med 2000; 17: 188–91.
60 A Mandelburg , Z Krupnik , S Houri Salbutamol metered dose inhaler with spacer for hyperkalemia. How fast? How safe? Chest 1999; 115: 617–22.
61 MA Perazella , RL Mahnensmith . Hyperkalemia in the elderly: drugs exacerbate impaired potassium homeostasis. J Gen Int Med 1997; 12: 646–56.
64 M Svensson , F Gustafsson , S Galatius , PR Hildebrandt , D Atar . How prevalent is hyperkalemia and renal dysfunction during treatment with spironolactone in patients with congestive heart failure? J Cardiac Failure 2004; 10: 297–303.
65 JV Butler , H McAvoy , D McEnroy , EC Mulkerrin . Spironolactone therapy in older patients – the impact of renal dysfunction. Arch Gerontol Geriatr 2002; 35: 45–49.
66 RB Payne , AJ Little , RB Williams , JR Milner . Interpretation of serum calcium in patients with abnormal serum proteins. Br Med J 1973; 4: 643–46.
67 JM Quesada , W Coopmans , B Ruiz , P Aljama , I Jans , R Bouillon . Influence of vitamin D on parathyroid function in the elderly. J Clin Endocrinol Metab 1992; 75 (2): 494–501.
68 KH Lau , DJ Baylink . Vitamin D therapy of osteoporosis: plain vitamin D therapy versus active vitamin D analog (D-hormone) therapy. Calcif Tissue Int 1999; 65: 295–306.
70 S Pattanaungkul , BL Riggs , AL Yergey , NE Vieira , WM O'Fallon , S Khosla . Relationship of intestinal calcium absorption to 1,25-dihydroxyvitamin D [1,25(OH)2D] levels in young versus elderly women: evidence for age-related intestinal resistance to 1,25(OH)2D action. J Clin Endocrinol Metab 2000; 85: 4023–27.
71 J MacLaughlin , MF Holick . Aging decreases the capacity of human skin to produce vitamin D3. J Clin Invest 1985; 76: 1536–38.
73 SJ Silverberg , E Shane , L de la Cruz , GV Segre , TL Clemens , JP Bilezikian . Abnormalities in parathyroid hormone secretion and 1,25-dihydroxyvitamin D3 formation in women with osteoporosis. NEJM 1989; 320: 277–81.
74 PL Munson , Hirsch PF. Importance of calcitonin in physiology, clinical pharmacology, and medicine. Bone Mineral 1992; 16: 162–65.
76 DB Endres , CH Morgan , PJ Garry , JL Omdahl . Age-related changes in serum immunoreactive parathyroid hormone and its biological action in healthy men and women. J Clin Endocrinol Metab 1987; 65: 724–31.
77 O Sahota , MK Mundey , P San , IM Godber , N Lawson , DJ Hosking . The relationship between vitamin D and parathyroid hormone: calcium homeostasis, bone turnover, and bone mineral density in postmenopausal women with established osteoporosis. Bone 2004; 35: 312–19.
78 D Rudman , MH Kutner , CM Rogers Impaired growth hormone secretion in the adult population: relation to age and adiposity. J Clin Invest 1981; 67: 1361–69.
79 RL Ferrini , E Barrett-Connor . Sex hormones and age: A cross-sectional study of testosterone and estradiol and their bioavailable fractions in community-dwelling men. Am J Epidemiol 1998; 147: 750–54.
80 JH Bassett , GR Williams . The molecular actions of thyroid hormone in bone. Trends Endocrinol Metabol 2003; 14: 356–64.
83 MK Thomas , DM Lloyd-Jones , RI Thadhani Hypovitaminosis D in medical inpatients. NEJM 1998; 338: 777–83.
85 G Macefield , D Burke . Paraesthesiae and tetany induced by voluntary hyperventilation. Increased excitability of human cutaneous and motor axons. Brain 1991; 114: 527–40.
86 PA Tambyah , BK Ong , KO Lee . Reversible Parkinsonism and asymptomatic hypocalcemia with basal ganglia calcification from hypoparathyroidism 26 years after thyroid surgery. Am J Med 1993; 94: 444.
87 T Meyer , V Ruppert , K Karatolios , B Maisch . Hereditary long QT syndrome due to autoimmune hypoparathyroidism in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome. J Electrocardiol 2007; 40: 504–9.
88 MS Cooper , NJ Gittoes . Diagnosis and management of hypocalcaemia. Br Med J 2008; 336: 1298–1302.
89 EM Newman , M Bouvet , S Borgehi , DA Herold , LJ Deftos . Causes of hypercalcemia in a population of military veterans in the United States. Endocr Pract 2006; 12: 535–41.
90 S Khosla , EJ Atkinson , LJ Melton , BL Riggs . Effects of age and estrogen status on serum parathyroid hormone levels and biochemical markers of bone turnover in women: a population-based study. J Clin Endocrinol Metab 1997; 82: 1522–27.
91 BM Rothschild . Paget's disease of the elderly. Compr Ther 2000; 26 (4): 251–54.
92 CJ Cheng , CH Chou , SH Lin . An unrecognized cause of recurrent hypercalcemia: immobilization. South Med J 2006; 99: 371–74.
93 O Lamy , P Burckhardt . Hypercalcemia of malignancy: diagnosis and treatment options. Am J Can 2002; 1: 277–92.
94 JR Weisinger , E Bellorin-Font . Magnesium and phosphorus. Lancet 1998; 352: 391–96.
95 EM Weiss-Guillet , J Takala , SM Jakob . Diagnosis and management of electrolyte emergencies. Best Pract Res Clin Endocrinol Metab 2003; 17: 623–51.
96 HJ Armbrecht , CJ Gross , TV Zenser . Effect of dietary calcium and phosphorus restriction on calcium and phosphorus balance in young and old rats. Arch Biochem Biophys 1981; 210: 179–85.
97 V Sorribas , M Lotscher , J Loffing Cellular mechanisms of the age-related decrease in renal phosphate reabsorption. Kidney Int 1996; 50: 855–63.
98 N Kagansky , S Levy , N Koren-Morag , D Berger , H Knobler . Hypophosphataemia in old patients is associated with the refeeding syndrome and reduced survival. J Intern Med 2005; 257: 461–68.
99 L Larsson , K Rebel , B Sorbo . Severe hypophosphate – a hospital survey. Acta Medica Scan 1983; 214: 221–23.
100 L Haglin , LA Burman , M Nilsson . High prevalence of hypophosphataemia amongst patients with infectious diseases. A retrospective study. J Int Med 1999; 246: 45–52.
101 V Barak , A Schwartz , I Kalickman , B Nisman , G Gurman , Y Shoenfeld . Prevalence of hypophosphatemia in sepsis and infection: the role of cytokines. Am J Med 1998; 104: 40–47.
103 R Subramanian , R Khardori . Severe hypophosphatemia. Pathophysiologic implications, clinical presentations, and treatment. Medicine 2000; 79: 1–8.
104 JP Machiels , A Dive , J Donckier , E Installe . Reversible myocardial dysfunction in a patient with alcoholic ketoacidosis: a role for hypophosphatemia. Am J Emerg Med 1998; 16: 371–73.
105 JD Melvin , RG Watts . Severe hypophosphatemia: a rare cause of intravascular haemolysis. Am J Hematol 2002; 69: 223–24.
107 AJ Larner . Pseudohyperphosphatemia. Clin Biochem 1995; 28: 391–93.
109 MM Lemos , ADB Jancikic , FMR Sanches Pulse wave velocity – a useful tool for cardiovascular surveillance in pre-dialysis patients. Nephrol Dial Transplant 2007; 22: 3527–32.
110 E Slatopolsky . New developments in hyperphosphatemia management. J Am Soc Nephrol 2003; 14: S297–9.
111 F Locatelli , JB Cannata-Andia , TB Drueke Management of disturbances of calcium and phosphate metabolism in chronic renal insufficiency, with emphasis on the control of hyperphosphataemia. Nephrol Dial Transplant 2002; 17: 723–31.